waypoint wealth counsel Buys Shares of 1,742 Globe Life Inc. $GL

waypoint wealth counsel bought a new stake in shares of Globe Life Inc. (NYSE:GL) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,742 shares of the company’s stock, valued at approximately $217,000.

Other hedge funds have also recently added to or reduced their stakes in the company. AdvisorNet Financial Inc lifted its holdings in shares of Globe Life by 60.0% in the second quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock valued at $28,000 after buying an additional 84 shares during the period. Amalgamated Bank raised its position in shares of Globe Life by 0.5% during the first quarter. Amalgamated Bank now owns 16,348 shares of the company’s stock worth $2,153,000 after purchasing an additional 85 shares during the period. Envestnet Portfolio Solutions Inc. raised its position in shares of Globe Life by 0.5% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 19,776 shares of the company’s stock worth $2,605,000 after purchasing an additional 89 shares during the period. Venturi Wealth Management LLC raised its position in shares of Globe Life by 1.1% during the first quarter. Venturi Wealth Management LLC now owns 8,226 shares of the company’s stock worth $1,084,000 after purchasing an additional 93 shares during the period. Finally, HighPoint Advisor Group LLC raised its position in shares of Globe Life by 4.2% during the first quarter. HighPoint Advisor Group LLC now owns 2,366 shares of the company’s stock worth $293,000 after purchasing an additional 95 shares during the period. Institutional investors own 81.61% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on GL shares. JPMorgan Chase & Co. boosted their target price on Globe Life from $145.00 to $160.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. Wells Fargo & Company boosted their target price on Globe Life from $150.00 to $172.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. BMO Capital Markets reaffirmed a “market perform” rating and set a $149.00 target price (up from $114.00) on shares of Globe Life in a research report on Wednesday, July 30th. Cfra Research raised Globe Life to a “moderate buy” rating in a research report on Friday, July 25th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of Globe Life in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $155.70.

Insider Transactions at Globe Life

In other Globe Life news, EVP Michael Clay Majors sold 10,000 shares of the business’s stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $137.41, for a total value of $1,374,100.00. Following the transaction, the executive vice president owned 47,066 shares in the company, valued at $6,467,339.06. The trade was a 17.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of the business’s stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $141.38, for a total value of $1,767,250.00. Following the completion of the transaction, the chief executive officer owned 32,747 shares in the company, valued at $4,629,770.86. This trade represents a 27.63% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 84,722 shares of company stock worth $11,733,793. 1.97% of the stock is owned by company insiders.

Globe Life Stock Performance

Shares of GL stock opened at $135.71 on Monday. Globe Life Inc. has a 1-year low of $100.27 and a 1-year high of $147.83. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $10.99 billion, a price-to-earnings ratio of 10.85 and a beta of 0.55. The stock’s fifty day simple moving average is $140.22 and its 200-day simple moving average is $128.76.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, beating analysts’ consensus estimates of $3.25 by $0.02. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the previous year, the company posted $2.97 earnings per share. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. On average, sell-side analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be paid a $0.27 dividend. The ex-dividend date is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life’s payout ratio is 8.63%.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.